David A. Siegel Harpoon Therapeutics, Inc. Transaction History

Two Sigma Advisers, LP

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.94 - $2.56 $2,068 - $5,632	-2,200 Reduced 4.12%	51,200 $50,000
Q2 2022 Aug 15, 2022	SELL	$1.78 - $5.02 $90,424 - $255,015	-50,800 Reduced 48.75%	53,400 $102,000
Q1 2022 May 16, 2022	SELL	$3.54 - $8.08 $462,324 - $1.06 Million	-130,600 Reduced 55.62%	104,200 $518,000
Q4 2021 Feb 14, 2022	SELL	$5.69 - $7.83 $811,963 - $1.12 Million	-142,700 Reduced 37.8%	234,800 $1.77 Million
Q3 2021 Nov 15, 2021	BUY	$7.88 - $14.0 $2.97 Million - $5.29 Million	377,500 New	377,500 $2.98 Million
Q2 2021 Aug 16, 2021	SELL	$13.81 - $23.25 $599,354 - $1.01 Million	-43,400 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$17.65 - $24.16 $303,580 - $415,552	-17,200 Reduced 28.38%	43,400 $908,000
Q4 2020 Feb 16, 2021	SELL	$12.83 - $17.84 $109,055 - $151,640	-8,500 Reduced 12.3%	60,600 $1.01 Million
Q3 2020 Nov 16, 2020	BUY	$11.01 - $18.52 $533,985 - $898,220	48,500 Added 235.44%	69,100 $1.17 Million
Q2 2020 Aug 14, 2020	BUY	$11.11 - $24.72 $66,660 - $148,320	6,000 Added 41.1%	20,600 $342,000
Q1 2020 May 15, 2020	BUY	$10.74 - $16.32 $40,812 - $62,016	3,800 Added 35.19%	14,600 $169,000
Q4 2019 Feb 14, 2020	BUY	$12.94 - $20.58 $139,752 - $222,263	10,800 New	10,800 $160,000

353K

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.